[Risk factors associated to adverse drug events in hospitalized patients].

María Del Rocío Hernández-Morales, Jorge Manuel Ramírez-Sánchez, Eleazar Mancilla-Hernández, Norma Lara-Dávalos, Samara Nazarala-Sanchez, Margarita Aguirre-Barbosa
{"title":"[Risk factors associated to adverse drug events in hospitalized patients].","authors":"María Del Rocío Hernández-Morales, Jorge Manuel Ramírez-Sánchez, Eleazar Mancilla-Hernández, Norma Lara-Dávalos, Samara Nazarala-Sanchez, Margarita Aguirre-Barbosa","doi":"10.29262/ram.v71i1.1169","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To determine prevalence, causes and risk factors of ADE in hospitalized patients.</p><p><strong>Methods: </strong>Analytical, observational, case-control study of patients with ADE. For statistical analysis, the following were calculated: percentages, frequencies, averages; odds ratio, χ<sup>2</sup> test and multiple binary logistic regression. Data analysis was carried out with the Statistical Package, for the Social Sciences 23 program.</p><p><strong>Results: </strong>A 132 patients were registered: 66 cases (26 EM and 40 RAM) and 66 controls; with average age of 35 years (SD 17.41). The prevalence of adverse drug events was 3.6%. The most frequently reported medications: antibiotics and anti-inflammatories. The frequency of adverse events by gender was: 39.3% men and 60.7% women. The services with the greatest patient care: emergencies, surgery; the most frequent route of administration: intravenous (32.3%). The main symptoms: skin. (32.3%) frequent symptoms: cutaneous. Associated symptoms RAM: type A pruritus (OR: 8.5; p = 0.001; IC95%: 0.035-0.393), type B pruritus (OR: 11; p = 0.001; CI95%: 0.021-0.368) urticaria (OR: 19; p = 0.005; IC95%: 0.007-0.412). Risk factors Associated EAM: female (OR: 2.6; p = 0.05; CI95%: 1.33-5.43), history of allergy (OR: 3.4; p = 0.033; CI95%: 1.04-8.40), prolonged hospital stays (OR: 5.4; p = 0.023; IC95%: 3.82-6.74).</p><p><strong>Conclusions: </strong>Patient safety is a priority when prescribing any drug, which represents a key point in prevention.</p>","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 1","pages":"1-7"},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29262/ram.v71i1.1169","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To determine prevalence, causes and risk factors of ADE in hospitalized patients.

Methods: Analytical, observational, case-control study of patients with ADE. For statistical analysis, the following were calculated: percentages, frequencies, averages; odds ratio, χ2 test and multiple binary logistic regression. Data analysis was carried out with the Statistical Package, for the Social Sciences 23 program.

Results: A 132 patients were registered: 66 cases (26 EM and 40 RAM) and 66 controls; with average age of 35 years (SD 17.41). The prevalence of adverse drug events was 3.6%. The most frequently reported medications: antibiotics and anti-inflammatories. The frequency of adverse events by gender was: 39.3% men and 60.7% women. The services with the greatest patient care: emergencies, surgery; the most frequent route of administration: intravenous (32.3%). The main symptoms: skin. (32.3%) frequent symptoms: cutaneous. Associated symptoms RAM: type A pruritus (OR: 8.5; p = 0.001; IC95%: 0.035-0.393), type B pruritus (OR: 11; p = 0.001; CI95%: 0.021-0.368) urticaria (OR: 19; p = 0.005; IC95%: 0.007-0.412). Risk factors Associated EAM: female (OR: 2.6; p = 0.05; CI95%: 1.33-5.43), history of allergy (OR: 3.4; p = 0.033; CI95%: 1.04-8.40), prolonged hospital stays (OR: 5.4; p = 0.023; IC95%: 3.82-6.74).

Conclusions: Patient safety is a priority when prescribing any drug, which represents a key point in prevention.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[住院病人药物不良事件的相关风险因素]。
目的:确定住院患者 ADE 的发生率、原因和风险因素:确定住院患者 ADE 的发病率、原因和风险因素:对 ADE 患者进行分析、观察和病例对照研究。统计分析的计算方法包括:百分比、频率、平均值、几率比、χ2 检验和多元二元逻辑回归。数据分析使用社会科学统计软件包 23 程序进行:共登记了 132 名患者:66 例病例(26 例 EM 和 40 例 RAM)和 66 例对照组;平均年龄为 35 岁(SD 17.41)。药物不良反应发生率为 3.6%。最常报告的药物是抗生素和消炎药。按性别分列的不良反应发生率为男性占 39.3%,女性占 60.7%。对患者照顾最多的服务:急诊、手术;最常见的给药途径:静脉注射(32.3%)。主要症状:皮肤。(经常出现的症状:皮肤(32.3%)。相关症状RAM:A型瘙痒症(OR:8.5;P=0.001;IC95%:0.035-0.393),B型瘙痒症(OR:11;P=0.001;CI95%:0.021-0.368)荨麻疹(OR:19;P=0.005;IC95%:0.007-0.412)。与 EAM 相关的风险因素:女性(OR:2.6;p = 0.05;CI95%:1.33-5.43)、过敏史(OR:3.4;p = 0.033;CI95%:1.04-8.40)、长期住院(OR:5.4;p = 0.023;IC95%:3.82-6.74):在开具任何药物处方时,患者安全都是首要考虑的问题,这也是预防的关键点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Adenovirus-related acute liver failure treated with intravenous immunoglobulin]. [Allergic contact dermatitis due to Furacin®]. [Chronic urticaria as an atypical reaction after a vespid bite]. [Epidemiological profile of allergic respiratory disease in Mexican children]. [Knowledge of mothers of children under 5 years of age about vaccination schedule].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1